ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,026,000 | +325.7% | 645,400 | +885.3% | 0.07% | +407.1% |
| Q3 2018 | $241,000 | -56.5% | 65,500 | -66.6% | 0.01% | -56.2% |
| Q2 2018 | $554,000 | +48.9% | 195,900 | +95.3% | 0.03% | +33.3% |
| Q1 2018 | $372,000 | -81.6% | 100,300 | -85.7% | 0.02% | -77.8% |
| Q4 2017 | $2,018,000 | +61.6% | 701,000 | +152.0% | 0.11% | +61.2% |
| Q3 2017 | $1,249,000 | +39.1% | 278,200 | +42.1% | 0.07% | +21.8% |
| Q2 2017 | $898,000 | -70.0% | 195,800 | -72.4% | 0.06% | -70.9% |
| Q1 2017 | $2,989,000 | -26.0% | 710,100 | -27.4% | 0.19% | -43.1% |
| Q4 2016 | $4,041,000 | +480.6% | 978,600 | +1037.9% | 0.33% | +492.9% |
| Q3 2016 | $696,000 | -52.9% | 86,000 | -54.6% | 0.06% | -59.4% |
| Q2 2016 | $1,477,000 | +65.8% | 189,400 | +64.0% | 0.14% | +53.3% |
| Q1 2016 | $891,000 | – | 115,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |